Giulio Marchesini

Citata da

	Tutte	Dal 2020
Citazioni	94931	38273
Indice H	117	70
i10-index	423	266

8000

4000

2000

6000

20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025244 310 491 663 1085 1366 1603 1883 2053 2231 2549 2879 3041 3161 3444 3656 5000 5448 6011 6274 7295 7902 7808 7481 7075 679

Accesso pubblico

Visualizza tutto

36 articoli

4 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Giampaolo BianchiUniversità di BolognaEmail verificata su unibo.it
Riccardo Dalle GraveVilla Garda Hospital, Department of Eating and Weight DisordersEmail verificata su adacentroobesitaanoressia.it
Salvatore PettaRicercatore di Gastroenterologia, Università di PalermoEmail verificata su unipa.it
Maria Letizia PetroniUniversity of BolognaEmail verificata su unibo.it
Antonio CraxiFull Professor of Gastroenterology and Internal Medicine, PROMISE, University of Palermo, ItalyEmail verificata su unipa.it
Calogero CammàSection of Gastroenterology, University of PalermoEmail verificata su unipa.it
Luca ValentiAssociate Professor of Internal Medicine, Università degli Studi di Milano, Fondazione Ca' GrandaEmail verificata su unimi.it
C DayNewcastle UniversityEmail verificata su ncl.ac.uk
Licata AnnaAssociate Professor of Internal MedicineEmail verificata su unipa.it
Zobair YounossiThe Global NASH CouncilEmail verificata su cldq.org
Helena Cortez-PintoClínica Universitária de Gastrenterologia, Faculdade de Medicina, Universidade de LisboaEmail verificata su medicina.ulisboa.pt
Amalia GastaldelliInstitute of Clinical Physiology, CNREmail verificata su cnr.it
Amedeo LonardoMedicina Interna USL ModenaEmail verificata su ausl.mo.it
Luca MieleFondazione Pol. Univ. A. Gemelli IRCCS, Università Cattolica Sacro Cuore. RomaEmail verificata su policlinicogemelli.it
Riccardo BonadonnaFull Professor of Endocrinology and Metabolism, University of Verona, ItalyEmail verificata su univr.it
Quentin M. AnsteeProfessor of Experimental Hepatology, Newcastle University, UKEmail verificata su newcastle.ac.uk
Compare AngeloUniversità di BergamoEmail verificata su unibg.it
Edoardo MannucciDirettore Agenzia Diabetologia, AOU Careggi, FirenzeEmail verificata su unifi.it
Fabrizio De PontiProfessor of Pharmacology, University of BolognaEmail verificata su unibo.it
Apolone GiovanniScientific Directorate, IRCCS INT, Milan, ItalyEmail verificata su istitutotumori.mi.it

Segui

Giulio Marchesini

Professor of Medicine, University of Bologna

Email verificata su unibo.it

metabolism liver diabetes obesity


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes B Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, ... New England Journal of Medicine 373 (22), 2117-2128, 2015	13827	2015
Empagliflozin and progression of kidney dsease in type 2 diabetes C Wanner, SE Inzucchi, JM Lachin, D Fitchett, M von Eynatten, ... New england journal of medicine 375 (4), 323-334, 2016	3974	2016
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD P Angulo, JM Hui, G Marchesini, E Bugianesi, J George, GC Farrell, ... Hepatology 45 (4), 846-854, 2007	3736	2007
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome G Marchesini, E Bugianesi, G Forlani, F Cerrelli, M Lenzi, R Manini, ... Hepatology 37 (4), 917-923, 2003	3724	2003
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome G Marchesini, M Brizi, G Bianchi, S Tomassetti, E Bugianesi, M Lenzi, ... Diabetes 50 (8), 1844-1850, 2001	3497	2001
EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, H Tilg, ... Journal of Hepatology 64 (6), 1388-1402, 2016	2782*	2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of nonalcoholic fatty liver disease EA the Study of the Liver (EASL), EA the Study of Diabetes (EASD), ... Journal of Hepatology 64 (6), 1388-1402, 2016	2771*	2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease European Association for The Study of The Liver, ... Obesity facts 9 (2), 65-90, 2016	2771	2016
A randomized, controlled trial of 3.0 mg of liraglutide in weight management X Pi‑Sunyer, A Astrup, K Fujioka, F Greenway, A Halpern, M Krempf, ... New England Journal of Medicine 373 (1), 11-22, 2015	2493	2015
Association of nonalcoholic fatty liver disease with insulin resistance G Marchesini, M Brizi, AM Morselli-Labate, G Bianchi, E Bugianesi, ... The American journal of medicine 107 (5), 450-455, 1999	2301	1999
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma E Bugianesi, N Leone, E Vanni, G Marchesini, F Brunello, P Carucci, ... Gastroenterology 123 (1), 134-140, 2002	1918	2002
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study G Bedogni, L Miglioli, F Masutti, C Tiribelli, G Marchesini, S Bellentani Hepatology 42 (1), 44-52, 2005	1902	2005
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018	1852	2018
A position statement on NAFLD/NASH based on the EASL 2009 special conference V Ratziu, S Bellentani, H Cortez-Pinto, C Day, G Marchesini Journal of hepatology 53 (2), 372-384, 2010	1499	2010
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019	1211	2019
Insulin resistance: a metabolic pathway to chronic liver disease E Bugianesi, AJ McCullough, G Marchesini Hepatology 42 (5), 987-1000, 2005	1197	2005
Metformin in non-alcoholic steatohepatitis G Marchesini, G Bianchi, S Tomassetti, M Zoli, N Melchionda The Lancet 358 (9285), 893-894, 2001	1114	2001
Clinical features and natural history of nonalcoholic steatosis syndromes Y Falck-Ytter, ZM Younossi, G Marchesini, AJ McCullough Seminars in liver disease 21 (01), 017-026, 2001	1050	2001
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease E Bugianesi, E Gentilcore, R Manini, S Natale, E Vanni, N Villanova, ... The American journal of gastroenterology 100 (5), 1082, 2005	1035	2005
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ... Hepatology 48 (3), 792-798, 2008	915	2008

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori